New Drug Might Reduce an Alzheimer's Marker: Study (HealthDay)
04/02/2012
Source: HealthDay
By Steven Reinberg, HealthDay reporter
Dr. David J. Langer, Director of Cerebrovascular Research at Cushing Neuroscience Institute, comments on a study about possible benefits the drug bapineuzumab may have on patients with mild to moderate Alzheimer's disease.
Read the full story.